论文部分内容阅读
目的探讨锶-89联合热疗治疗骨转移癌的疗效。方法将70例患者随机分为两组,实验组(35例)接受锶-89联合热疗治疗,对照组(35例)接受锶-89治疗,观察治疗2周后两组的镇痛疗效及体力情况。结果治疗2周后实验组的癌痛缓解率为82.8%,对照组为60%,两组比较差异有统计学意义(P<0.05)。实验组和对照组KPS改善率分别为57.1%和31.4%,差异有统计学意义(P<0.05)。结论锶-89联合热疗可以控制骨转移癌引起的疼痛;锶-89联合热疗可作为临床治疗骨痛的一种较理想的选择。
Objective To investigate the efficacy of strontium-89 combined with hyperthermia in the treatment of bone metastases. Methods Seventy patients were randomly divided into two groups. The experimental group (35 cases) was treated with strontium-89 combined with hyperthermia and the control group (35 cases) received strontium-89 treatment. The analgesic efficacy was observed in two groups after treatment for two weeks Physical condition. Results After 2 weeks of treatment, the cancer pain relief rate was 82.8% in the experimental group and 60% in the control group. There was significant difference between the two groups (P <0.05). The improvement rates of KPS in experimental group and control group were 57.1% and 31.4%, respectively, the difference was statistically significant (P <0.05). Conclusion Strontium-89 combined with hyperthermia can control the pain caused by bone metastases; strontium-89 combined with hyperthermia can be used as a more ideal choice for clinical treatment of bone pain.